262 related articles for article (PubMed ID: 30365116)
1. Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial‑mesenchymal transition mediated by the FAK/AKT/MMPs axis.
Liu SQ; Xu CY; Wu WH; Fu ZH; He SW; Qin MB; Huang JA
Int J Oncol; 2019 Jan; 54(1):41-52. PubMed ID: 30365116
[TBL] [Abstract][Full Text] [Related]
2. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.
Xu CY; Liu SQ; Qin MB; Zhuge CF; Qin L; Qin N; Lai MY; Huang JA
Int J Mol Med; 2017 May; 39(5):1277-1284. PubMed ID: 28405684
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules.
Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD
Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649
[TBL] [Abstract][Full Text] [Related]
4. SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer.
Wu JN; Lin L; Luo SB; Qiu XZ; Zhu LY; Chen D; Wei ED; Fu ZH; Qin MB; Liang ZH; Huang JA; Liu SQ
Cancer Med; 2021 Sep; 10(17):6010-6021. PubMed ID: 34268882
[TBL] [Abstract][Full Text] [Related]
5. SphK1 promotes tumor cell migration and invasion in colorectal cancer.
Long J; Xie Y; Yin J; Lu W; Fang S
Tumour Biol; 2016 May; 37(5):6831-6. PubMed ID: 26662312
[TBL] [Abstract][Full Text] [Related]
6. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of MMP‑1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c‑myc signaling pathway and EMT.
Wang K; Zheng J; Yu J; Wu Y; Guo J; Xu Z; Sun X
Oncol Rep; 2020 Apr; 43(4):1103-1112. PubMed ID: 32323782
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
Su YL; Luo HL; Huang CC; Liu TT; Huang EY; Sung MT; Lin JJ; Chiang PH; Chen YT; Kang CH; Cheng YT
Cells; 2020 Mar; 9(4):. PubMed ID: 32225123
[TBL] [Abstract][Full Text] [Related]
9. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
11. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
[TBL] [Abstract][Full Text] [Related]
13. [Sphingosine kinase 1 enhances the proliferation and invasion of human colon cancer LoVo cells through up-regulating FAK pathway and the expression of ICAM-1 and VCAM-1].
Liu SQ; Su YJ; Huang JA; Qin MB; Tang GD
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):331-6. PubMed ID: 24054007
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FAK inhibits the invasion and metastasis of Tca‑8113 cells in vitro.
Xiao W; Jiang M; Li H; Li C; Su R; Huang K
Mol Med Rep; 2013 Aug; 8(2):703-7. PubMed ID: 23807215
[TBL] [Abstract][Full Text] [Related]
15. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
16. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
17. SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway.
Chen WF; Gao WD; Li QL; Zhou PH; Xu MD; Yao LQ
Int J Colorectal Dis; 2013 Jul; 28(7):933-40. PubMed ID: 23314850
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
[TBL] [Abstract][Full Text] [Related]
19. Sphk1 participates in malignant progression of breast cancer by regulating epithelial-mesenchymal transition and stem cell characteristics.
Chen Z; Liu B
Tissue Cell; 2020 Aug; 65():101380. PubMed ID: 32746988
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K/AKT activation and MMP-2/9 production in vitro.
Yuan H; Yang P; Zhou D; Gao W; Qiu Z; Fang F; Ding S; Xiao W
Mol Biol Rep; 2014 Aug; 41(8):5157-65. PubMed ID: 24816639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
